StockData
QIAGEN N.V. logo

QIAGEN N.V. (QGEN) stock

QGENNYSEBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
Financials through fiscal 2025, year ended Dec 31, 2025Last filing: 20-F on Mar 20, 2026Score 10/30
$49.75−0.06 (-0.12%)

Close on Nov 17, 2026Market cap $10.79BP/E 25.6Yield 0.50%

Qiagen total assets

Total assets on the balance sheet at the end of each period.

Qiagen's total assets was $6.28B at Dec 31, 2025. For fiscal 2025 it was $6.28B, up 10.4% from the year before. Over ten years it grew 4.2% a year on average. The highest annual figure on record is $6.29B in fiscal 2022.

Annual total assets

PeriodPeriod endValueChange
FY2025Dec 31, 2025$6.28B+10.4%
FY2024Dec 31, 2024$5.69B-7.0%
FY2023Dec 31, 2023$6.12B-2.7%
FY2022Dec 31, 2022$6.29B+2.3%
FY2021Dec 31, 2021$6.15B+4.7%
FY2020Dec 31, 2020$5.87B+12.1%
FY2019Dec 31, 2019$5.24B-8.9%
FY2018Dec 31, 2018$5.75B+14.1%
FY2017Dec 31, 2017$5.04B+17.0%
FY2016Dec 31, 2016$4.31B+3.1%
FY2015Dec 31, 2015$4.18B-6.2%
FY2014Dec 31, 2014$4.45B+9.0%
FY2013Dec 31, 2013$4.09B+0.0%
FY2012Dec 31, 2012$4.09B+9.6%
FY2011Dec 31, 2011$3.73B-4.7%
FY2010Dec 31, 2010$3.91B+3.1%
FY2009Dec 31, 2009$3.80B–

Quarterly total assets

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q4 FY2025Dec 31, 2025$6.28B+2.2%
Q4 FY2024Dec 31, 2024$5.69B-3.1%
Q4 FY2023Dec 31, 2023$6.12B+16.8%
Q4 FY2022Dec 31, 2022$6.29B+9.4%
Q4 FY2021Dec 31, 2021$6.15B+22.0%
Q4 FY2020Dec 31, 2020$5.87B+36.2%
Q4 FY2019Dec 31, 2019$5.24B+25.3%
Q4 FY2018Dec 31, 2018$5.75B+29.0%
Q4 FY2017Dec 31, 2017$5.04B+23.2%
Q4 FY2016Dec 31, 2016$4.31B+5.4%
Q4 FY2015Dec 31, 2015$4.18B+12.1%
Q4 FY2014Dec 31, 2014$4.45B+13.8%
Q4 FY2013Dec 31, 2013$4.09B+7.7%
Q4 FY2012Dec 31, 2012$4.09B–
Q4 FY2011Dec 31, 2011$3.73B–
Q4 FY2010Dec 31, 2010$3.91B–
Q4 FY2009Dec 31, 2009$3.80B–

More Qiagen figures

See a number that looks wrong?